false
zh-CN,zh-TW,en,fr,de,ja,ko,pt,es,th,vi
Catalog
ACMG Education Workgroups
What's New in Neurotherapeutics? Review of Select ...
What's New in Neurotherapeutics? Review of Select Treatments Approved for Rare Neurological Disorders
Back to course
Pdf Summary
The document is a feedback summary of a course on new neurotherapeutic treatments for rare neurological disorders. It presents various statistics and participant comments, highlighting key elements of the course experience in order to evaluate its effectiveness and areas for improvement. <br /><br />Most participants expressed high satisfaction, with a 100% agreement that the course content met expectations, particularly appreciating discussions on gene therapy and treatments for spinal muscular atrophy (SMA) and other neurogenetic disorders like Rett syndrome and Batten disease. The course effectively communicated contemporary advancements and practical insights into therapeutic developments, generating enthusiasm among attendees.<br /><br />Some of the key takeaways reported by participants included advancements in newborn screening, understanding the mechanisms of action of treatments, and their applicability in pediatric care. Many found the information on new and emerging treatment options valuable for clinical practice.<br /><br />The survey also revealed that while some participants were keen on practical applications, others faced limited direct applicability due to their current professional roles (e.g., non-patient-facing jobs or semi-retirement). Despite this, there was a clear emphasis on the importance of expanding awareness and preparedness for early diagnosis through proactive knowledge sharing.<br /><br />Feedback on the presentations indicated that while they were deemed informative and effective, a few participants noted pacing issues, suggesting that some presentations seemed rushed or overloaded with content. It was also suggested that future programs could benefit from including patient or family perspectives to enhance understanding and engagement.<br /><br />Overall, the course was well-received, and it successfully enhanced participant knowledge on new treatments and strategies for managing rare neurological disorders.
Keywords
neurotherapeutic treatments
rare neurological disorders
gene therapy
spinal muscular atrophy
neurogenetic disorders
newborn screening
pediatric care
early diagnosis
participant feedback
course effectiveness
© 2024 American College of Medical Genetics and Genomics. All rights reserved.
×